Invacare Total Long Term Liabilities 2010-2023 | IVCRQ

Invacare total long term liabilities from 2010 to 2023. Total long term liabilities can be defined as the sum of all non-current liabilities.
Invacare Annual Total Long Term Liabilities
(Millions of US $)
2022 $470
2021 $444
2020 $382
2019 $325
2018 $329
2017 $425
2016 $260
2015 $128
2014 $108
2013 $149
2012 $342
2011 $367
2010 $338
2009 $368
Invacare Quarterly Total Long Term Liabilities
(Millions of US $)
2023-03-31 $520
2022-12-31 $470
2022-09-30 $454
2022-06-30 $437
2022-03-31 $445
2021-12-31 $444
2021-09-30 $452
2021-06-30 $448
2021-03-31 $432
2020-12-31 $382
2020-09-30 $380
2020-06-30 $306
2020-03-31 $268
2019-12-31 $325
2019-09-30 $330
2019-06-30 $342
2019-03-31 $364
2018-12-31 $329
2018-09-30 $393
2018-06-30 $446
2018-03-31 $432
2017-12-31 $425
2017-09-30 $418
2017-06-30 $385
2017-03-31 $252
2016-12-31 $260
2016-09-30 $261
2016-06-30 $267
2016-03-31 $272
2015-12-31 $128
2015-09-30 $126
2015-06-30 $134
2015-03-31 $105
2014-12-31 $108
2014-09-30 $127
2014-06-30 $169
2014-03-31 $166
2013-12-31 $149
2013-09-30 $170
2013-06-30 $226
2013-03-31 $225
2012-12-31 $342
2012-09-30 $371
2012-06-30 $375
2012-03-31 $370
2011-12-31 $367
2011-09-30 $403
2011-06-30 $355
2011-03-31 $347
2010-12-31 $338
2010-09-30 $341
2010-06-30 $355
2010-03-31 $356
2009-12-31 $368
2009-09-30 $416
2009-06-30 $471
2009-03-31 $469
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47